Latest news
Apogee Therapeutics Positive Interim Results From Phase 1b Trial Of Zumilokibart (APG777) | Jan 06 Gorton School Lockdown (mvSdngPTwI) - MshaleMshale · Tue, 11 Aug 2026 06:04:47 GMTApogee Therapeutics reports Q2 2026 results; cash and marketable securities $1.3B, net loss $85.9M - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMTAbbVie to Acquire Apogee Therapeutics for $10.9 Billion; Apogee Reports Positive Phase 2 Zumilokibart Data and Q2 2026 Results - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 11:15:00 GMTJanus (JBI) Reports Q2: Everything You Need To Know Ahead Of Earnings - TradingViewTradingView · Mon, 10 Aug 2026 03:03:00 GMT